3004
India tightens drug licence rules
India has proposed rules requiring regulators to immediately suspend manufacturing licences for medicines that fail quality standards in government testing.
The licence would remain suspended until the manufacturer provides a root-cause analysis and corrective actions to the regulator’s satisfaction.
Source: TradingView



